CLINICAL_TRIALS
trial_result
· 2012-12-19
Clinical Trial Update: A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis [Phase 2]
Summary
This entry summarizes the results of a Phase 2 safety and effectiveness study of CNTO 1275 in adults with moderate to severe plaque-type psoriasis. The trial st…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centocor, Inc. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2012-12-19